A Single Patient IND for PD-0325901

Prior Treatment With PD-0325901 With Ongoing Clinical Response Clinical Trial

Official title:

A Phase I Single Patient IND for PD-0325901

Clinical Trial Details — Status: No longer available

Administrative data

• NCT number: NCT02297802
• Other study ID #: 130596 SHRP
• Status: No longer available
• Phase: Phase 1
• First received: May 12, 2014
• Last updated: November 24, 2014
• Start date: June 2013
• Est. completion date: July 2013

Study information

• Verified date: November 2014
• Source: Sharp HealthCare
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Expanded Access

Clinical Trial Summary

The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.

Recruitment information / eligibility

• Status: No longer available
• Enrollment: 0
• Est. completion date: July 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Prior treatment with PD-0325901 with ongoing response

Exclusion Criteria:

Study Design

N/A

Related Conditions & MeSH terms

• Prior Treatment With PD-0325901 With Ongoing Clinical Response

Intervention

Drug:
• PD-0325901

Locations

Country	Name	City	State
United States	Sharp Healthcare	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
Sharp HealthCare

Country where clinical trial is conducted

United States,